Role of Angiotensin II in Cellular Entry and Replication of Dengue Virus

Overview

Journal Arch Virol

Specialty Microbiology

Date 2024 May 16

PMID 38753119

Authors

Adriana Pedreanez

Yenddy Carrero

Renata Vargas

Juan P Hernandez-Fonseca

Jesus Alberto Mosquera

Affiliations

Soon will be listed here.

Abstract

Previous studies have demonstrated the relevance of several soluble molecules in the pathogenesis of dengue. In this regard, a possible role for angiotensin II (Ang II) in the pathophysiology of dengue has been suggested by the observation of a blockade of Ang II in patients with dengue, increased expression of molecules related to Ang II production in the plasma of dengue patients, increased expression of circulating cytokines and soluble molecules related to the action of Ang II, and an apparent relationship between DENV, Ang II effects, and miRNAs. In addition, in ex vivo experiments, the blockade of Ang II AT1 receptor and ACE-1 (angiotensin converting enzyme 1), both of which are involved in Ang II production and its function, inhibits infection of macrophages by DENV, suggesting a role of Ang II in viral entry or in intracellular viral replication of the virus. Here, we discuss the possible mechanisms of Ang II in the entry and replication of DENV. Ang II has the functions of increasing the expression of DENV entry receptors, creation of clathrin-coated vesicles, and increasing phagocytosis, all of which are involved in DENV entry. This hormone also modulates the expression of the Rab5 and Rab7 proteins, which are important in the endosomal processing of DENV during viral replication. This review summarizes the data related to the possible involvement of Ang II in the entry of DENV into cells and its replication.

References

Brady O, Gething P, Bhatt S, Messina J, Brownstein J, Hoen A . Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012; 6(8):e1760. PMC: 3413714. DOI: 10.1371/journal.pntd.0001760. View

Messina J, Brady O, Scott T, Zou C, Pigott D, Duda K . Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014; 22(3):138-46. PMC: 3946041. DOI: 10.1016/j.tim.2013.12.011. View

Recker M, Vannice K, Hombach J, Jit M, Simmons C . Assessing dengue vaccination impact: Model challenges and future directions. Vaccine. 2016; 34(38):4461-4465. DOI: 10.1016/j.vaccine.2016.06.082. View

Screaton G, Mongkolsapaya J, Yacoub S, Roberts C . New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015; 15(12):745-59. DOI: 10.1038/nri3916. View

Halstead S, Nimmannitya S, Cohen S . Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970; 42(5):311-28. PMC: 2591704. View

Littaua R, Kurane I, Ennis F . Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990; 144(8):3183-6. View

Kontny U, Kurane I, Ennis F . Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol. 1988; 62(11):3928-33. PMC: 253818. DOI: 10.1128/JVI.62.11.3928-3933.1988. View

Dalrymple N, Mackow E . Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol. 2011; 85(18):9478-85. PMC: 3165770. DOI: 10.1128/JVI.05008-11. View

Cruz-Oliveira C, Freire J, Conceicao T, Higa L, Castanho M, Da Poian A . Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev. 2015; 39(2):155-70. DOI: 10.1093/femsre/fuu004. View

10.

Mukhopadhyay S, Kuhn R, Rossmann M . A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2004; 3(1):13-22. DOI: 10.1038/nrmicro1067. View

11.

Martina B, Koraka P, Osterhaus A . Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009; 22(4):564-81. PMC: 2772360. DOI: 10.1128/CMR.00035-09. View

12.

Mosquera-Sulbaran J, Pedreanez A, Hernandez-Fonseca J, Hernandez-Fonseca H . Angiotensin II and dengue. Arch Virol. 2023; 168(7):191. DOI: 10.1007/s00705-023-05814-6. View

13.

Hunyady L, Catt K . Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2005; 20(5):953-70. DOI: 10.1210/me.2004-0536. View

14.

Dandona P, Dhindsa S, Ghanim H, Chaudhuri A . Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2006; 21(1):20-7. DOI: 10.1038/sj.jhh.1002101. View

15.

Hernandez-Fonseca J, Duran A, Valero N, Mosquera J . Losartan and enalapril decrease viral absorption and interleukin 1 beta production by macrophages in an experimental dengue virus infection. Arch Virol. 2015; 160(11):2861-5. PMC: 7086732. DOI: 10.1007/s00705-015-2581-1. View

16.

Timmermans P, Wong P, Chiu A, Herblin W, Benfield P, Carini D . Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 45(2):205-51. View

17.

van Kats J, Danser A, van Meegen J, Sassen L, Verdouw P, SCHALEKAMP M . Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation. 1998; 98(1):73-81. DOI: 10.1161/01.cir.98.1.73. View

18.

Kobori H, Prieto-Carrasquero M, Ozawa Y, Navar L . AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension. 2004; 43(5):1126-32. PMC: 2637079. DOI: 10.1161/01.HYP.0000122875.91100.28. View

19.

Moulik S, Speth R, Turner B, Rowe B . Angiotensin II receptor subtype distribution in the rabbit brain. Exp Brain Res. 2002; 142(2):275-83. DOI: 10.1007/s00221-001-0940-5. View

20.

De Mello W . Effect of extracellular and intracellular angiotensins on heart cell function; on the cardiac renin-angiotensin system. Regul Pept. 2003; 114(2-3):87-90. DOI: 10.1016/s0167-0115(03)00121-6. View